Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Dynavax hepatitis B vaccine gets FDA nod on third try, shares upDynavax hepatitis B vaccine gets FDA nod on third try, shares up
    Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent salesRegeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales
    Zydus Cadila, Intas Pharma under CDSCO scanner for launching Unapproved drugZydus Cadila, Intas Pharma under CDSCO scanner for launching Unapproved drug
    Granules India posts Q2 net profit at Rs 40 croreGranules India posts Q2 net profit at Rs 40 crore
    Piramal group expands healthcare project ASARAPiramal group expands healthcare project ASARA
    Novartis takes fight to Pfizers Ibrance with new Kisqali dataNovartis takes fight to Pfizers Ibrance with new Kisqali data
    Manipal Health appoints Dilip Jose as MD and CEOManipal Health appoints Dilip Jose as MD and CEO
    GSK appoints scientist Barron as new Research and Development headGSK appoints scientist Barron as new Research and Development head
    Thousands of drugs at risk if no Brexit deal, companies warnThousands of drugs at risk if no Brexit deal, companies warn
    MORE DRUGS added to the Schedule H listMORE DRUGS added to the Schedule H list
    Mylan seeks EMA approval for 2 biosimilarsMylan seeks EMA approval for 2 biosimilars
    Alembic Pharma Q2 net rises over 1 percent to Rs 121 croreAlembic Pharma Q2 net rises over 1 percent to Rs 121 crore
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok